Background: Rhabdomyosarcoma (RMS) is a malignant tumor with varying outcomes based on the current diagnosis and treatment system. This current retrospective study aims to predict the prognosis of patients for further providing a proper treatment by identifying the factors influencing the prognosis of RMS in children. Methods: We collected the demographic, clinical, therapeutic, and prognostic information of 64 patients aged under 18 years diagnosed with RMS from January 2014 to June 2021. Overall survival (OS) curves were measured by the Kaplan-Meier method. The prognostic values of OS were assessed by using the Cox proportional hazards regression model with univariate and multivariate analyses. Results: Of the 64 patients, effects of each factor as followed: age, gender, Ki-67, family background, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and risk classification on OS, were researched. Univariate analysis suggested that age >10 years (HR: 9.13, 95% CI, 3.19-26.17), NLR > 1 (HR: 3.43, 95% CI, 1.28¬9.23), PLR < 110 (HR: 0.17, 95% CI, 0.06-0.46) and risk classification, including Intermediate- and High-risk group (HR: 28.30, 95% CI, 3.44-232.77 and HR: 113.59, 95% CI, 12.59-1024.48) were associated with OS. Multivariate analysis showed that only age (HR: 4.957, 95% CI, 1.227-20.026) and risk classification, including Intermediate- and High-risk group (HR: 44.28, 95% CI, 4.02-486.87 and HR: 372. 70, 95% CI, 21.05-6598.08) affected the prognosis significantly. Conclusions: Older children are more inclined to higher risk stratifications and poor prognosis, consistent with some previous studies. This study showed that OS for RMS is dependent on age and risk classification which is crucial for clinical practice.